|
|
| Business Week
|
Bristol-Myers to licence AIDS drug in India, Africa
2/16/2006 4:22:34 PM (GMT +2)
CHICAGO, - Bristol-Myers Squibb on Wednesday said it cut a deal with two generic drugmakers to allow cheap versions of its newest AIDS drug to be made in sub-Saharan Africa and India, where millions suffer from the disease.
|
|
Bristol-Myers said it will license and lend technical expertise for its drug Reyataz to generic manufacturers Aspen PharmaCare of South Africa and Emcure Pharmaceuticals of India.
Reyataz is a once-daily protease inhibitor, a second-line treatment for AIDS for patients who stop responding to the first-choice drugs.
The number of patients in the developing world taking first-line anti-retroviral drugs increased after drugmakers came under pressure to improve access to the drugs. But that has led to drug resistance, creating the need for more expensive second-line drugs.
|
|
|
